Zacks: Brokerages Expect CME Group Inc. (NASDAQ:CME) Will Announce Quarterly Sales of $1.18 Billion

Brokerages expect that CME Group Inc. (NASDAQ:CME) will post sales of $1.18 billion for the current quarter, Zacks reports. Five analysts have provided estimates for CME Group’s earnings, with estimates ranging from $1.11 billion to $1.23 billion. CME Group posted sales of $1.08 billion during the same quarter last year, which suggests a positive year over year growth rate of 9.3%. The firm is scheduled to announce its next quarterly earnings results before the market opens on Wednesday, October 27th.

According to Zacks, analysts expect that CME Group will report full year sales of $4.81 billion for the current financial year, with estimates ranging from $4.66 billion to $4.91 billion. For the next fiscal year, analysts anticipate that the firm will report sales of $5.12 billion, with estimates ranging from $4.95 billion to $5.23 billion. Zacks’ sales calculations are an average based on a survey of research firms that cover CME Group.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 28th. The financial services provider reported $1.64 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.59 by $0.05. The company had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.17 billion. CME Group had a return on equity of 8.33% and a net margin of 41.64%.

CME has been the topic of several analyst reports. Morgan Stanley lifted their price target on shares of CME Group from $228.00 to $229.00 and gave the stock an “equal weight” rating in a report on Thursday, July 1st. TheStreet downgraded shares of CME Group from a “b” rating to a “c+” rating in a research report on Wednesday, August 18th. Finally, Atlantic Securities upgraded shares of CME Group from a “neutral” rating to an “overweight” rating and set a $230.00 price target for the company in a research report on Tuesday. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, CME Group presently has an average rating of “Hold” and an average price target of $210.83.

In related news, Director Martin J. Gepsman sold 1,000 shares of CME Group stock in a transaction dated Monday, August 30th. The stock was sold at an average price of $201.00, for a total value of $201,000.00. Following the completion of the sale, the director now directly owns 27,368 shares in the company, valued at $5,500,968. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Sean Tully sold 5,000 shares of CME Group stock in a transaction dated Tuesday, August 24th. The shares were sold at an average price of $200.20, for a total value of $1,001,000.00. Following the transaction, the insider now owns 23,479 shares in the company, valued at approximately $4,700,495.80. The disclosure for this sale can be found here. Insiders sold 9,000 shares of company stock valued at $1,786,150 over the last three months. 0.30% of the stock is owned by insiders.

Hedge funds have recently bought and sold shares of the stock. Simon Quick Advisors LLC raised its position in CME Group by 33.3% in the first quarter. Simon Quick Advisors LLC now owns 200 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 50 shares during the last quarter. Beaumont Financial Partners LLC lifted its holdings in shares of CME Group by 2.6% in the second quarter. Beaumont Financial Partners LLC now owns 1,943 shares of the financial services provider’s stock valued at $413,000 after purchasing an additional 50 shares in the last quarter. Marcum Wealth LLC lifted its holdings in CME Group by 4.0% during the second quarter. Marcum Wealth LLC now owns 1,298 shares of the financial services provider’s stock worth $276,000 after acquiring an additional 50 shares during the period. Brandywine Oak Private Wealth LLC lifted its holdings in CME Group by 0.8% during the first quarter. Brandywine Oak Private Wealth LLC now owns 6,331 shares of the financial services provider’s stock worth $1,293,000 after acquiring an additional 52 shares during the period. Finally, Eqis Capital Management Inc. raised its stake in shares of CME Group by 1.1% in the second quarter. Eqis Capital Management Inc. now owns 4,665 shares of the financial services provider’s stock valued at $992,000 after buying an additional 52 shares during the period. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Shares of CME Group stock traded down $0.38 on Thursday, hitting $188.85. 1,136,072 shares of the company traded hands, compared to its average volume of 1,443,937. The company has a market cap of $67.82 billion, a PE ratio of 35.30 and a beta of 0.43. CME Group has a 52 week low of $146.89 and a 52 week high of $221.82. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock’s 50 day moving average price is $204.38 and its 200-day moving average price is $208.14.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 27th. Shareholders of record on Friday, September 10th will be paid a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 1.91%. The ex-dividend date of this dividend is Thursday, September 9th. CME Group’s dividend payout ratio is presently 53.57%.

About CME Group

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

See Also: Initial Coin Offering (ICO)

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.